Krystal Biotech Inc header image

Krystal Biotech Inc

KRYS

Equity

ISIN null / Valor 38026052

NASDAQ (2026-10-09)

USD 331.61+1.32%

Krystal Biotech Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Krystal Biotech Inc is a biotechnology company that specializes in developing gene therapies for various genetic diseases. Their first commercial product, VYJUVEK®, is a redosable gene therapy designed to treat dystrophic epidermolysis bullosa. The company is focused on advancing innovative treatments that address unmet medical needs in the field of genetic disorders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

75.7%1Y

183%3Y

543%5Y

Performance

38.1%1Y

47.5%3Y

61.6%5Y

Volatility

9815 M

Market cap (USD)

196,961

Daily traded volume (Shares)

160.055 / 154.99

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

CG Oncology Inc

CG Oncology Inc Valor: 131996952

Annual Return

-50%0%+50%

Risk level

110

0.89%USD 63.82

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

4.18%USD 19.45

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

0.69%SEK 263.70

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

0.48%USD 65.35

Agenus Inc

Agenus Inc Valor: 134326284

Annual Return

-50%0%+50%

Risk level

110

1.72%USD 7.67

Tempus AI Inc

Tempus AI Inc Valor: 135855934

Annual Return

-50%0%+50%

Risk level

110

2.38%USD 70.93

Concentra Group Holdings Parent Inc

Concentra Group Holdings Parent Inc Valor: 136105334

Annual Return

-50%0%+50%

Risk level

110

1.58%USD 37.19

Lineage Inc

Lineage Inc Valor: 136372357

Annual Return

-50%0%+50%

Risk level

110

-0.03%USD 34.43

Helen of Troy Ltd

Helen of Troy Ltd Valor: 938381

Annual Return

-50%0%+50%

Risk level

110

-0.15%USD 26.51

BioVersys AG

BioVersys AG Valor: 21036264

Annual Return

-50%0%+50%

Risk level

110

0.00%CHF 26.50

SIX

FactSet

Clearbit

Logos provided by Clearbit